Vertex Pharmaceuticals(VRTX.US) Officer Sells US$1.02 Million in Common Stock

$Vertex Pharmaceuticals(VRTX.US)$ Officer Bozic Carmen sold 2,280 shares of common stock on May 29, 2024 at an average price of $445.56 for a total value of $1.02 million.Source: Announcement What is

Futu News16:11

Analyst Expectations For Vertex Pharmaceuticals's Future

During the last three months, 10 analysts shared their evaluations of Vertex Pharmaceuticals (NASDAQ:VRTX), revealing diverse outlooks from bullish to bearish.The following table summarizes their rece

BenzingaMay 31 10:01

Form 144 | Vertex Pharmaceuticals(VRTX.US) Officer Proposes to Sell 1 Million in Common Stocks

SEC FILLINGS DISCLOSED/ May 31, $Vertex Pharmaceuticals(VRTX.US)$ Officer Tatsis Ourania intends to sell 2,250 shares of its common stock on May 31, with a total market value of approximately $1 milli

Futu NewsMay 31 09:59

Vertex Pharmaceuticals Is Maintained at Outperform by BMO Capital

Vertex Pharmaceuticals Is Maintained at Outperform by BMO Capital

Dow JonesMay 31 08:52

BMO Capital Maintains Outperform on Vertex Pharmaceuticals, Raises Price Target to $500

BMO Capital analyst Evan Seigerman maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and raises the price target from $480 to $500.

BenzingaMay 31 08:42

Vertex Pharmaceuticals Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 12.65% BMO Capital $480 → $500 Maintains Outperform 05/07/2024 -4.47% RBC Capital $417 → $424 M

BenzingaMay 31 08:41